Sitemap Contact Privacy Statement Imprint

Curriculum Vitae Simon Jäger

Affiliation
Resident physician in Clinical Pharmacology at Dr. Margarete Fischer-Bosch-Institute for Clinical Pharmacology in Stuttgart, and University of Tübingen

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Auerbachstr. 112
D-70376 Stuttgart
phone: ++49-711-8101 2090
fax: ++49-711-859295
email: simon.jaeger@ikp-stuttgart.de
Simon Jäger

++49-711-8101 2090

Education and Professional Career
2001-2008 Studies in Human Medicine at the University of Würzburg, Germany, University of Rochester, USA, and University of Buenos Aires, Argentina
2008-2017 Training in Internal Medicine, Robert Bosch Krankenhaus, Investigator in 13 clinical trials in the field of inflammatory bowel disease, Expert Certificate for Inflammatory Bowel Disease (DGVS)
2009 Doctoral Thesis "Surveillance des Barrett-Ösophagus – Vergleich konservative Therapie versus Anti-Reflux-Operation“, (Prof. Dr. med. Dr. rer. nat. M. Fein, Surgical University Clinic, University of Würzburg, Germany)
2010-2012 Research Grant from DFG and Robert-Bosch-Stiftung (Gerok Program), Project Title: “Regulation of the redox status of hBD-1 (humanes ß-Defensin 1) in inflammatory bowel disease
2011 ECFMG Certificate, “MD” (License to practice medicine in the USA)
2017 Board Certificate in Internal Medicine
2017 Research Grant from Robert Bosch Stiftung, Project Title: „The balance between hypoxia-induced autophagy and NLRP3 activation is shifted towards inflammation in inflammatory bowel disease” at UniversitätsSpital Zürich, Clinical of Gastroenterology (Prof. Dr. med. Dr. phil. Gerhard Rogler)
Since 2017 Resident physician in Clinical Pharmacology and Postdoctoral Research Fellow (Prof. Dr. med. M. Schwab)
Selected References
  • Tacrolimus suppositories in therapy-resistant ulcerative proctitis. Simon U Jaeger, Thomas Klag, Katharina Hoeger, Siegfried Klumpp, Markus Escher, Nisar Malek, Eduard Stange, Jan Wehkamp. Accepted Manuscript (Inflammatory Intestinal Diseases), 2018 Sept
  • Inflammatory bowel disease: an impaired barrier disease. Jäger S, Stange EF, Wehkamp J. Langenbecks Arch Surg. 2013 Jan;398(1):1-12
  • Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry. Hofmann U, Heinkele G, Angelberger S, Schaeffeler E, Lichtenberger C, Jaeger S, Reinisch W, Schwab M. Anal Chem. 2012 Feb 7;84(3):1294-301
Major Projects
  • Implementation of pharmacogenetics into the clinic
  • Conduct and design of clinical studies (ADRED, TAMENDOX, BST204C02)
  • Personalized cancer therapy using organoid cultures in colorectal cancer
  • TPMT diagnostics and pharmacogenetics of thiopurine metabolism